Pharmaust Phase II K9 Trial, page-39

I think you may have missed NZT’s point about the uptake of canine chemotherapy.
Due to cost, side effects, access etc, only 20% of owners allow their pet to undertake chemo. It’s been a fairly constant number for years.
What we have targets the other 80% of owners.
THAT’S why the canine market is potentially enormous.

And that is before any potential uses in humans: which is when the serious money (MM’s post) starts getting talked out.